Mahdi Shahriarinour
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mahdi Shahriarinour has a total of 74 co-authors. Here are the top co-authors by number of shared publications:
- Najmeh Ranji
Department of Biology, Ra.C., Islamic Azad University, Rasht, Iran
8 shared publications Najmeh Ranji
Department of Biology, Islamic Azad University, Ra.C., Rasht, Iran
7 shared publicationsHossein Zahmatkesh
Department of Biology, University of Guilan, Rasht, Iran
5 shared publications- Mohammad Nikpassand
Department of Chemistry, Ra.C., Islamic Azad University, Rasht, Iran
5 shared publications Mohammad Nikpassand
Department of Chemistry, Ra.C., Islamic Azad University, Rasht, Iran
4 shared publicationsBehnam Rasti
Department of Microbiology, La.C., Islamic Azad University, Lahijan, Iran
3 shared publications
Latest Publications
- Open Access
- 7 July 2026
- Published by Springer Nature in BMC Biotechnology
Dual antimicrobial and anticancer functions of artemisinin-loaded PEG400-oa nanoparticles: synergistic activity with ciprofloxacin and mechanistic insights from molecular docking
Artemisinin, a bioactive compound from Artemisia annua with potent antioxidant, antimicrobial and anticancer properties, faces limited clinical utility due to poor solubility and low bioavailability. Given the rising prevalence of multidrug-resistant (MDR) Pseudomonas aeruginosa alternative therapeutic strategies are essential. This study synthesized and characterized artemisinin-loaded micelle/liposome nanoparticles (Art/PEG400-OA NPs) and evaluated their antibacterial, antibiofilm, and anticancer efficacy. Artemisinin was successfully encapsulated within PEG400-OA NPs and characterized via FT-IR, FE-SEM, TEM, TGA, and zeta potential measurements. The nanoparticles exhibited uniform morphology, particle sizes of 40.8 nm (TEM) and 149.8 nm (FE-SEM), high encapsulation efficiency (92.14%), and strong thermal and colloidal stability. Synergistic and partial synergistic interactions between Art/PEG400-OA NPs and ciprofloxacin were observed in MDR bacterial samples, significantly inhibiting biofilm formation. Quantitative RT-PCR analysis revealed the downregulation of efflux pump genes (mexA, mexB, mexX, mexY, oprM) and biofilm-associated genes (algD, pelA) following combination therapy. In AGS gastric cancer cells, Art/PEG400-OA NPs induced dose- and time-dependent cytotoxicity (IC₅₀: 67.75, 62.25 and 54.98 µg/mL at 24, 48 and 72 h), increased apoptosis (31.76% ± 4.2%), and reduced wound-healing migration (56.65% ± 4.26%). Expression analysis demonstrated upregulation of tumor-suppressive miR-34a, and downregulation of its targets (CTNNB1, TGFB1, MMP2 and MMP9). Conversely, miR-181a was downregulated, leading to the upregulation of apoptotic target genes (TP53, CASP8, CASP9). Molecular docking supported strong artemisinin binding to key bacterial and oncogenic proteins. Overall, Art/PEG400-OA nanoparticles represent a potent dual-action nanotherapeutic platform against antibiotic-resistant infections and gastric cancer.
- 7 July 2026
- Published by Springer Nature in BMC Biotechnology
Open AccessDual antimicrobial and anticancer functions of artemisinin-loaded PEG400-oa nanoparticles: synergistic activity with ciprofloxacin and mechanistic insights from molecular docking
Artemisinin, a bioactive compound from Artemisia annua with potent antioxidant, antimicrobial and anticancer properties, faces limited clinical utility due to poor solubility and low bioavailability. Given the rising prevalence of multidrug-resistant (MDR) Pseudomonas aeruginosa alternative therapeutic strategies are essential. This study synthesized and characterized artemisinin-loaded micelle/liposome nanoparticles (Art/PEG400-OA NPs) and evaluated their antibacterial, antibiofilm, and anticancer efficacy. Artemisinin was successfully encapsulated within PEG400-OA NPs and characterized via FT-IR, FE-SEM, TEM, TGA, and zeta potential measurements. The nanoparticles exhibited uniform morphology, particle sizes of 40.8 nm (TEM) and 149.8 nm (FE-SEM), high encapsulation efficiency (92.14%), and strong thermal and colloidal stability. Synergistic and partial synergistic interactions between Art/PEG400-OA NPs and ciprofloxacin were observed in MDR bacterial samples, significantly inhibiting biofilm formation. Quantitative RT-PCR analysis revealed the downregulation of efflux pump genes (mexA, mexB, mexX, mexY, oprM) and biofilm-associated genes (algD, pelA) following combination therapy. In AGS gastric cancer cells, Art/PEG400-OA NPs induced dose- and time-dependent cytotoxicity (IC₅₀: 67.75, 62.25 and 54.98 µg/mL at 24, 48 and 72 h), increased apoptosis (31.76% ± 4.2%), and reduced wound-healing migration (56.65% ± 4.26%). Expression analysis demonstrated upregulation of tumor-suppressive miR-34a, and downregulation of its targets (CTNNB1, TGFB1, MMP2 and MMP9). Conversely, miR-181a was downregulated, leading to the upregulation of apoptotic target genes (TP53, CASP8, CASP9). Molecular docking supported strong artemisinin binding to key bacterial and oncogenic proteins. Overall, Art/PEG400-OA nanoparticles represent a potent dual-action nanotherapeutic platform against antibiotic-resistant infections and gastric cancer.
- Open Access
- 23 May 2026
- Published by Springer Nature in BMC Biotechnology
- Vol. 26 (1)
Anticancer effects of bisabolol oxide A-Loaded Micellar/Liposomal nanoparticles on DU-145 cells with deregulation of miR-34a and miR-181a: in silico and in vitro studies
Bisabolol oxide A, a key bioactive constituent of Matricaria chamomilla, is recognized for its potent anti-inflammatory, antioxidant, and anticancer properties. This study focused on synthesizing bisabolol oxide A-loaded micellar/liposomal nanoparticles (NPs) and rigorously evaluating their anti-proliferative and anti-invasive effects using integrated in vitro and in silico methodologies. Physicochemical characterization of the bisabolol oxide A-loaded NPs was performed using SEM, TEM, TGA-DTG, Zeta potential, DLS analysis, and FT-IR spectroscopy. Furthermore, drug-like properties for bisabolol oxide A, bisabolol oxide B, and 5,8,11-heptadecatriynoic acid methyl ester were predicted using Swiss ADME software. Molecular dynamics simulations were subsequently conducted for these compounds against critical cellular migration proteins: β-catenin and the Epidermal Growth Factor Receptor (EGFR). The anticancer efficacy of the bisabolol oxide A-loaded nanoparticles was assessed through MTT assays, Annexin V/PI staining, wound healing assays, and qRT-PCR. Characterizations confirmed that the nanoparticles possessed optimal characteristics, exhibiting sizes between 35 to 67 nm, high mono-dispersity and thermal stability up to 380°C. In vitro results demonstrated that bisabolol oxide A-loaded micellar/liposomal nanoparticles significantly inhibited DU-145 cell proliferation, yielding IC₅₀ value of 55.44 µg/mL, 46.21 µg/mL, and 43.59 µg/mL after 24, 48, and 72 hours of treatment. Flow-cytometry analysis further confirmed 50.04% reduced migratory capacity and induction of apoptosis. Mechanistically, qRT-PCR analysis revealed a significant 2.31 ± 0.16-fold upregulation of the tumor-suppressive miR-34a and a 1.72 ± 0.03-fold downregulation of the oncomiR miR-181a in treated cells. These miRNA alterations correlated with the downregulation of migration-associated genes (CTNNB, SMAD3, and EGFR) and the upregulation of apoptosis-related genes (P53 and CASP9), findings substantiated by Western blot analysis. In silico analyses indicated favorable ADMET properties for bisabolol oxide A, bisabolol oxide B, and 5,8,11-heptadecatriyneoic acid methyl ester. Molecular docking simulations revealed strong binding affinities of these compounds for β-catenin and EGFR, which are key proteins in cellular migration pathways. Our findings strongly suggest that bisabolol oxide A functions as an anti-migration and pro-apoptotic agent by effectively modulating the expression of specific miRNAs and their transcriptional targets, complemented by potent inhibitory interactions with critical protein targets.
- 23 May 2026
- Published by Springer Nature in BMC Biotechnology
- Vol. 26 (1)
Open AccessAnticancer effects of bisabolol oxide A-Loaded Micellar/Liposomal nanoparticles on DU-145 cells with deregulation of miR-34a and miR-181a: in silico and in vitro studies
Bisabolol oxide A, a key bioactive constituent of Matricaria chamomilla, is recognized for its potent anti-inflammatory, antioxidant, and anticancer properties. This study focused on synthesizing bisabolol oxide A-loaded micellar/liposomal nanoparticles (NPs) and rigorously evaluating their anti-proliferative and anti-invasive effects using integrated in vitro and in silico methodologies. Physicochemical characterization of the bisabolol oxide A-loaded NPs was performed using SEM, TEM, TGA-DTG, Zeta potential, DLS analysis, and FT-IR spectroscopy. Furthermore, drug-like properties for bisabolol oxide A, bisabolol oxide B, and 5,8,11-heptadecatriynoic acid methyl ester were predicted using Swiss ADME software. Molecular dynamics simulations were subsequently conducted for these compounds against critical cellular migration proteins: β-catenin and the Epidermal Growth Factor Receptor (EGFR). The anticancer efficacy of the bisabolol oxide A-loaded nanoparticles was assessed through MTT assays, Annexin V/PI staining, wound healing assays, and qRT-PCR. Characterizations confirmed that the nanoparticles possessed optimal characteristics, exhibiting sizes between 35 to 67 nm, high mono-dispersity and thermal stability up to 380°C. In vitro results demonstrated that bisabolol oxide A-loaded micellar/liposomal nanoparticles significantly inhibited DU-145 cell proliferation, yielding IC₅₀ value of 55.44 µg/mL, 46.21 µg/mL, and 43.59 µg/mL after 24, 48, and 72 hours of treatment. Flow-cytometry analysis further confirmed 50.04% reduced migratory capacity and induction of apoptosis. Mechanistically, qRT-PCR analysis revealed a significant 2.31 ± 0.16-fold upregulation of the tumor-suppressive miR-34a and a 1.72 ± 0.03-fold downregulation of the oncomiR miR-181a in treated cells. These miRNA alterations correlated with the downregulation of migration-associated genes (CTNNB, SMAD3, and EGFR) and the upregulation of apoptosis-related genes (P53 and CASP9), findings substantiated by Western blot analysis. In silico analyses indicated favorable ADMET properties for bisabolol oxide A, bisabolol oxide B, and 5,8,11-heptadecatriyneoic acid methyl ester. Molecular docking simulations revealed strong binding affinities of these compounds for β-catenin and EGFR, which are key proteins in cellular migration pathways. Our findings strongly suggest that bisabolol oxide A functions as an anti-migration and pro-apoptotic agent by effectively modulating the expression of specific miRNAs and their transcriptional targets, complemented by potent inhibitory interactions with critical protein targets.
- 20 February 2026
- Published by Springer Nature in 3 Biotech
- Vol. 16 (3) , 107
Synthesis of stable micelle/liposome nanocarriers to deliver silibinin into ciprofloxacin resistant isolates of Escherichia coli with effects on biofilm formation and efflux pumps
Silibinin-loaded micelle/liposome nanocarriers (SMLNs) were successfully synthesized and characterized using FT-IR, SEM, TEM, XRD and TGA analyses. The nanocarriers exhibited an average particle size of 16.33 nm as determined by TEM imaging and less than 60 nm by FE-SEM analysis. They displayed an amorphous structure, and high thermal stability, maintaining integrity at temperatures exceeding 650 °C. The silibinin loading content and entrapment efficiency were 3.2% and 83.3%, respectively. In vitro release studies demonstrated a rapid, pH-dependent release, achieving complete drug release within 60 min at pH 5.0 and 65 min at pH 7.4. The combination of SMLNs with ciprofloxacin produced strong synergistic antibacterial effects, reducing the minimum inhibitory concentration (MIC) of ciprofloxacin by 2- to 128-fold against resistant E. coli isolates. Biofilm formation decreased significantly under combination therapy compared with ciprofloxacin alone. Quantitative RT-PCR revealed that co-treatment downregulated efflux pump (acrA, acrB and tolC) and virulence (fimH and sfa) genes, while upregulating the repressor gene acrR. Molecular docking confirmed strong binding of silibinin to AcrAB-TolC, acrR, and fimH with binding affinities ranging from − 6.0 to − 8.9 kcal/mol.These findings demonstrate that SMLNs enhance the antibacterial efficacy of ciprofloxacin by inhibiting efflux pumps and biofilm formation, highlighting their potential as a multifunctional nanoplatform to combat antibiotic-resistant E. coli.
- 20 February 2026
- Published by Springer Nature in 3 Biotech
- Vol. 16 (3) , 107
Synthesis of stable micelle/liposome nanocarriers to deliver silibinin into ciprofloxacin resistant isolates of Escherichia coli with effects on biofilm formation and efflux pumps
Silibinin-loaded micelle/liposome nanocarriers (SMLNs) were successfully synthesized and characterized using FT-IR, SEM, TEM, XRD and TGA analyses. The nanocarriers exhibited an average particle size of 16.33 nm as determined by TEM imaging and less than 60 nm by FE-SEM analysis. They displayed an amorphous structure, and high thermal stability, maintaining integrity at temperatures exceeding 650 °C. The silibinin loading content and entrapment efficiency were 3.2% and 83.3%, respectively. In vitro release studies demonstrated a rapid, pH-dependent release, achieving complete drug release within 60 min at pH 5.0 and 65 min at pH 7.4. The combination of SMLNs with ciprofloxacin produced strong synergistic antibacterial effects, reducing the minimum inhibitory concentration (MIC) of ciprofloxacin by 2- to 128-fold against resistant E. coli isolates. Biofilm formation decreased significantly under combination therapy compared with ciprofloxacin alone. Quantitative RT-PCR revealed that co-treatment downregulated efflux pump (acrA, acrB and tolC) and virulence (fimH and sfa) genes, while upregulating the repressor gene acrR. Molecular docking confirmed strong binding of silibinin to AcrAB-TolC, acrR, and fimH with binding affinities ranging from − 6.0 to − 8.9 kcal/mol.These findings demonstrate that SMLNs enhance the antibacterial efficacy of ciprofloxacin by inhibiting efflux pumps and biofilm formation, highlighting their potential as a multifunctional nanoplatform to combat antibiotic-resistant E. coli.
- 6 February 2026
- Published by Springer Nature in Current Microbiology
- Vol. 83 (3) , 159
Synergistic Antibacterial Activity of Quercetin-Functionalized Magnetic Nanoparticles Combined with Ciprofloxacin on Pathogenic Pseudomonas Aeruginosa Via Targeting Virulence, Efflux Pump, and Adhesion-Associated Genes and Molecular Docking Analysis
Biofilm formation and the activity of efflux pumps are major contributors to antibiotic resistance in clinical strains of Pseudomonas aeruginosa and significantly enhance the pathogenicity of this bacterium. Functionalization of metal nanoparticles with plant-derived flavonoids, particularly when combined with conventional antibiotics, represents a promising strategy for overcoming antimicrobial resistance. In the present study, we investigated the synergistic inhibitory effects of quercetin-functionalized magnetic nanoparticles (Fe3O4@SiPr@Quercetin NPs) in combination with ciprofloxacin against ciprofloxacin-resistant clinical isolates of P. aeruginosa. Ciprofloxacin-resistant isolates were collected from hospitals and diagnostic laboratories in Tehran Province, Iran. The synthesized nanoparticles exhibited a spherical morphology with an average diameter of 165 nm. Synergistic antibacterial activity of the functionalized nanoparticles combined with ciprofloxacin was evaluated using the checkerboard assay. The most pronounced reduction in biofilm formation, was observed in strains treated with the nanoparticle–ciprofloxacin combination, with inhibition rates ranging from 18.9 ± 1.13% to 90.05 ± 5.72%. Time-kill curve analysis further demonstrated that Fe3O4@SiPr@Quercetin in combination with ciprofloxacin produced a more rapid bactericidal effect, reducing bacterial counts to 5.87–4.72 log CFU/mL after 8 h of treatment. Moreover, quantitative real-time PCR (qPCR) analysis revealed significant downregulation of genes associated with efflux pumps (mexA, mexB, oprM, mexX, and mexY) and virulence factors (pelA, algD, pslA, and exoS) in the clinical isolate treated with ½ minimum inhibitory concentration (MIC) of Fe3O4@SiPr@Quercetin in combination with ½ MIC of ciprofloxacin, compared with treatment with ciprofloxacin alone. Collectively, these findings indicate that quercetin-functionalized magnetic nanoparticles may serve as a promising adjunctive therapeutic strategy for combating ciprofloxacin-resistant P. aeruginosa infections.
- 6 February 2026
- Published by Springer Nature in Current Microbiology
- Vol. 83 (3) , 159
Synergistic Antibacterial Activity of Quercetin-Functionalized Magnetic Nanoparticles Combined with Ciprofloxacin on Pathogenic Pseudomonas Aeruginosa Via Targeting Virulence, Efflux Pump, and Adhesion-Associated Genes and Molecular Docking Analysis
Biofilm formation and the activity of efflux pumps are major contributors to antibiotic resistance in clinical strains of Pseudomonas aeruginosa and significantly enhance the pathogenicity of this bacterium. Functionalization of metal nanoparticles with plant-derived flavonoids, particularly when combined with conventional antibiotics, represents a promising strategy for overcoming antimicrobial resistance. In the present study, we investigated the synergistic inhibitory effects of quercetin-functionalized magnetic nanoparticles (Fe3O4@SiPr@Quercetin NPs) in combination with ciprofloxacin against ciprofloxacin-resistant clinical isolates of P. aeruginosa. Ciprofloxacin-resistant isolates were collected from hospitals and diagnostic laboratories in Tehran Province, Iran. The synthesized nanoparticles exhibited a spherical morphology with an average diameter of 165 nm. Synergistic antibacterial activity of the functionalized nanoparticles combined with ciprofloxacin was evaluated using the checkerboard assay. The most pronounced reduction in biofilm formation, was observed in strains treated with the nanoparticle–ciprofloxacin combination, with inhibition rates ranging from 18.9 ± 1.13% to 90.05 ± 5.72%. Time-kill curve analysis further demonstrated that Fe3O4@SiPr@Quercetin in combination with ciprofloxacin produced a more rapid bactericidal effect, reducing bacterial counts to 5.87–4.72 log CFU/mL after 8 h of treatment. Moreover, quantitative real-time PCR (qPCR) analysis revealed significant downregulation of genes associated with efflux pumps (mexA, mexB, oprM, mexX, and mexY) and virulence factors (pelA, algD, pslA, and exoS) in the clinical isolate treated with ½ minimum inhibitory concentration (MIC) of Fe3O4@SiPr@Quercetin in combination with ½ MIC of ciprofloxacin, compared with treatment with ciprofloxacin alone. Collectively, these findings indicate that quercetin-functionalized magnetic nanoparticles may serve as a promising adjunctive therapeutic strategy for combating ciprofloxacin-resistant P. aeruginosa infections.
- 7 January 2026
- Published by Springer Nature in International Microbiology
- Vol. 29 (2) , 197-213
Preparation of silibinin- dendrimer-stabilized Au nanoparticles for decreasing vancomycin resistance in S. aureus clinical isolates
Introduction Silibinin (SB), a bioactive flavonolignan derived from milk thistle seeds (Silybum marianum L.), exhibits well-documented antioxidant, antibacterial, antifungal, antiviral, and hepatoprotective activities. This study aimed to conjugate SB with fourth-generation poly(amidoamine) dendrimer-stabilized gold nanoparticles (DSA) to enhance its solubility and evaluate its antibacterial efficacy against clinical isolates of Staphylococcus aureus (S. aureus). Methods The morphology and structural features of silibinin-dendrimer-stabilized gold nanoparticle complex (SB-DSA) were characterized using Fourier-transform infrared spectroscopy (FTIR), dynamic light scattering (DLS), transmission electron microscopy (TEM) and field-emission scanning electron microscopy (FE-SEM). Antibacterial activity was assessed through biofilm formation assays, checkerboard analysis, and quantitative real-time PCR (qRT-PCR) using clinical S. aureus isolates and a standard reference strain. Results Physicochemical analyses confirmed the successful incorporation of SB into the DSA matrix. The average particle size of the SB-DSA nanocomposites was approximately 20 nm. A synergistic interaction between SB-DSA and vancomycin was observed, with SB-DSA significantly enhancing the susceptibility of vancomycin-resistant isolates to vancomycin. Biofilm formation was markedly reduced in resistant isolates treated with the SB-DSA/vancomycin combination compared with vancomycin alone. The time-kill kinetics of SB-DSA in the tested isolates ranged from 4 to 8 h. Combination treatment also resulted in downregulation of icaA, and norA expression in resistant S. aureus isolates. Conclusion Silibinin encapsulated within DSA demonstrates potent anti S. aureus activity, likely mediated through downregulation of efflux pump-related genes and improved intracellular retention of vancomycin. Consequently, even low concentrations of vancomycin, when combined with silibinin, effectively inhibited the growth of vancomycin-resistant isolates. Graphical abstract
- 7 January 2026
- Published by Springer Nature in International Microbiology
- Vol. 29 (2) , 197-213
Preparation of silibinin- dendrimer-stabilized Au nanoparticles for decreasing vancomycin resistance in S. aureus clinical isolates
Introduction Silibinin (SB), a bioactive flavonolignan derived from milk thistle seeds (Silybum marianum L.), exhibits well-documented antioxidant, antibacterial, antifungal, antiviral, and hepatoprotective activities. This study aimed to conjugate SB with fourth-generation poly(amidoamine) dendrimer-stabilized gold nanoparticles (DSA) to enhance its solubility and evaluate its antibacterial efficacy against clinical isolates of Staphylococcus aureus (S. aureus). Methods The morphology and structural features of silibinin-dendrimer-stabilized gold nanoparticle complex (SB-DSA) were characterized using Fourier-transform infrared spectroscopy (FTIR), dynamic light scattering (DLS), transmission electron microscopy (TEM) and field-emission scanning electron microscopy (FE-SEM). Antibacterial activity was assessed through biofilm formation assays, checkerboard analysis, and quantitative real-time PCR (qRT-PCR) using clinical S. aureus isolates and a standard reference strain. Results Physicochemical analyses confirmed the successful incorporation of SB into the DSA matrix. The average particle size of the SB-DSA nanocomposites was approximately 20 nm. A synergistic interaction between SB-DSA and vancomycin was observed, with SB-DSA significantly enhancing the susceptibility of vancomycin-resistant isolates to vancomycin. Biofilm formation was markedly reduced in resistant isolates treated with the SB-DSA/vancomycin combination compared with vancomycin alone. The time-kill kinetics of SB-DSA in the tested isolates ranged from 4 to 8 h. Combination treatment also resulted in downregulation of icaA, and norA expression in resistant S. aureus isolates. Conclusion Silibinin encapsulated within DSA demonstrates potent anti S. aureus activity, likely mediated through downregulation of efflux pump-related genes and improved intracellular retention of vancomycin. Consequently, even low concentrations of vancomycin, when combined with silibinin, effectively inhibited the growth of vancomycin-resistant isolates. Graphical abstract
- Open Access
- 15 December 2025
- Published by Springer Nature in BMC Biotechnology
- Vol. 25 (1) , 140
Augmentation of antibacterial activity of ciprofloxacin by bisabololoxide A encapsulated in polymeric nanoparticles against uropathogenic Escherichia coli
Multidrug-resistant uropathogenic Escherichia coli (UPEC) are a major cause of urinary tract infections, largely due to efflux pump overexpression, porin alterations, and increasing biofilm formation. To address these challenges, we developed bisabololoxide A-loaded PEG400-oleate polymeric nanoparticles (BAPNs) and evaluated their potential to enhance the efficacy of ciprofloxacin against ciprofloxacin-resistant isolates. BAPNs were synthesized and characterized by FTIR, TEM, FE-SEM, EDX, TGA, and zeta potential analysis. The synergistic effects of BAPNs and ciprofloxacin were evaluated in drug-resistant isolates. The inhibition of Biofilm formationwas quantified by crystal violet staining and gene expression changes in some genes related to efflux pumps, porins and biofilm formation were analyzed in two representative isolates by qPCR. BAPNs exhibited a spherical morphology with sizes ranging from 17 to 28 nm (TEM) and 30–43 nm (FE-SEM). Checkerboard analysis showed that the MIC of ciprofloxacin decreased by 2- to 32-fold in ciprofloxacin-resistant isolates and the ATCC 8739 strain when combined with BAPNs. Biofilm inhibition was significantly enhanced with the combined therapy compared to ciprofloxacin alone. qPCR analysis further revealed significant downregulation of the AcrAB-TolC efflux pump genes and the virulence genes fimH and hlyA, along with upregulation of the porin genes (ompC and ompF). Furthermore, molecular docking analysis confirmed the strong binding affinities of bisabololoxide A with virulence-associated proteins of E. coli. Our findings suggested that BAPNs may significantly potentiate ciprofloxacin activity by inhibiting efflux pump expression and biofilm formation, and increase of cell membrane permeability to drugs (with enhancing porins), thereby restoring susceptibility in resistant UPEC isolates. These results highlight BAPNs as a promising adjunctive nanocarrier strategy to overcome ciprofloxacin resistance in uropathogenic E. coli. Further validation in larger isolate panels and in vivo studies is warranted. The online version contains supplementary material available at 10.1186/s12896-025-01070-5.
- 15 December 2025
- Published by Springer Nature in BMC Biotechnology
- Vol. 25 (1) , 140
Open AccessAugmentation of antibacterial activity of ciprofloxacin by bisabololoxide A encapsulated in polymeric nanoparticles against uropathogenic Escherichia coli
Multidrug-resistant uropathogenic Escherichia coli (UPEC) are a major cause of urinary tract infections, largely due to efflux pump overexpression, porin alterations, and increasing biofilm formation. To address these challenges, we developed bisabololoxide A-loaded PEG400-oleate polymeric nanoparticles (BAPNs) and evaluated their potential to enhance the efficacy of ciprofloxacin against ciprofloxacin-resistant isolates. BAPNs were synthesized and characterized by FTIR, TEM, FE-SEM, EDX, TGA, and zeta potential analysis. The synergistic effects of BAPNs and ciprofloxacin were evaluated in drug-resistant isolates. The inhibition of Biofilm formationwas quantified by crystal violet staining and gene expression changes in some genes related to efflux pumps, porins and biofilm formation were analyzed in two representative isolates by qPCR. BAPNs exhibited a spherical morphology with sizes ranging from 17 to 28 nm (TEM) and 30–43 nm (FE-SEM). Checkerboard analysis showed that the MIC of ciprofloxacin decreased by 2- to 32-fold in ciprofloxacin-resistant isolates and the ATCC 8739 strain when combined with BAPNs. Biofilm inhibition was significantly enhanced with the combined therapy compared to ciprofloxacin alone. qPCR analysis further revealed significant downregulation of the AcrAB-TolC efflux pump genes and the virulence genes fimH and hlyA, along with upregulation of the porin genes (ompC and ompF). Furthermore, molecular docking analysis confirmed the strong binding affinities of bisabololoxide A with virulence-associated proteins of E. coli. Our findings suggested that BAPNs may significantly potentiate ciprofloxacin activity by inhibiting efflux pump expression and biofilm formation, and increase of cell membrane permeability to drugs (with enhancing porins), thereby restoring susceptibility in resistant UPEC isolates. These results highlight BAPNs as a promising adjunctive nanocarrier strategy to overcome ciprofloxacin resistance in uropathogenic E. coli. Further validation in larger isolate panels and in vivo studies is warranted. The online version contains supplementary material available at 10.1186/s12896-025-01070-5.
- Open Access
- 29 September 2025
- Published by Springer Nature in BMC Biotechnology
- Vol. 25 (1) , 1-12
N-Acetylcysteine as an anti-oxidant and anti-inflammatory agent in decreasing histopathological damages and oxidative stress after mercury exposure in lung tissue of rats
Mercury (Hg) is a naturally occurring heavy metal with high toxicitythat affects various organs. This study aimed to evaluate the protective effects of N-acetylcysteine (NAC) on the lung tissue of Wistar rats exposed to mercury. Rats were divided into five groups: H1 (control), H2 (single dose of Hg), H3 (continuous dose of Hg), H4 (single dose of Hg+ single dose of NAC), and H5 (continuous dose of Hg+ continuous dose of NAC). The expression levels of SOD1, NOS, TIMP1, Fibronectin1, HIF1, MPO, MMP2 and TIMP2 were analyzed using qRT-PCR. Mercury levels in the blood and lung tissues significantly increased in the H2 and H3 groups compared to the H4 and H5 groups, respectively. Hg exposure in H3 group significantly (P < 0.001) led to the upregulation of MPO (4.55-fold), HIF1(4.31-fold), MMP2 (4.20-fold), TIMP1(3.18-fold), TIMP2 (4.83-fold), NOS (3.52-fold), and FN1 (3.52-fold), along with the downregulation of SOD1 (0.51-fold) compare to control group (H1). In contrast, rats treated with NAC after Hg exposure in H5 group significantly (p < 0.01–0.001) showed downregulation of MPO (2.49-fold), HIF1(2.12-fold), MMP2 (1.94-fold), TIMP1(1.92-fold), TIMP2 (1.96-fold), NOS (2.00-fold), and FN1 (1.90-fold), and upregulation of SOD1 (0.76-fold) compare to H3 group. A significant reduction in mercury levels was also observed in the blood and lung tissue of rats treated with NAC compared to those exposed Hg alone. NAC exerts a protective effect against mercury-induced cytotoxicity and genotoxicity in rat lungs by scavenging mercury and modulating the expression of oxidative stress-related genes.
- 29 September 2025
- Published by Springer Nature in BMC Biotechnology
- Vol. 25 (1) , 1-12
Open AccessN-Acetylcysteine as an anti-oxidant and anti-inflammatory agent in decreasing histopathological damages and oxidative stress after mercury exposure in lung tissue of rats
Mercury (Hg) is a naturally occurring heavy metal with high toxicitythat affects various organs. This study aimed to evaluate the protective effects of N-acetylcysteine (NAC) on the lung tissue of Wistar rats exposed to mercury. Rats were divided into five groups: H1 (control), H2 (single dose of Hg), H3 (continuous dose of Hg), H4 (single dose of Hg+ single dose of NAC), and H5 (continuous dose of Hg+ continuous dose of NAC). The expression levels of SOD1, NOS, TIMP1, Fibronectin1, HIF1, MPO, MMP2 and TIMP2 were analyzed using qRT-PCR. Mercury levels in the blood and lung tissues significantly increased in the H2 and H3 groups compared to the H4 and H5 groups, respectively. Hg exposure in H3 group significantly (P < 0.001) led to the upregulation of MPO (4.55-fold), HIF1(4.31-fold), MMP2 (4.20-fold), TIMP1(3.18-fold), TIMP2 (4.83-fold), NOS (3.52-fold), and FN1 (3.52-fold), along with the downregulation of SOD1 (0.51-fold) compare to control group (H1). In contrast, rats treated with NAC after Hg exposure in H5 group significantly (p < 0.01–0.001) showed downregulation of MPO (2.49-fold), HIF1(2.12-fold), MMP2 (1.94-fold), TIMP1(1.92-fold), TIMP2 (1.96-fold), NOS (2.00-fold), and FN1 (1.90-fold), and upregulation of SOD1 (0.76-fold) compare to H3 group. A significant reduction in mercury levels was also observed in the blood and lung tissue of rats treated with NAC compared to those exposed Hg alone. NAC exerts a protective effect against mercury-induced cytotoxicity and genotoxicity in rat lungs by scavenging mercury and modulating the expression of oxidative stress-related genes.
- 12 July 2025
- Published by Springer Nature in 3 Biotech
- Vol. 15 (8) , 1-14
Anti-bacterial activity of silibinin-functionalized silica-coated Fe3O4 magnetic nanocomposites on Pseudomonas aeruginosa
The nanocomposites were synthesized and characterized using Fourier transform infrared spectroscopy (FT-IR), thermogravimetric analysis (TGA), transmission electron microscopy (TEM), field emission scanning electron microscopy (FE-SEM), and X-ray diffraction (XRD). The physicochemical analyses confirmed the structural integrity, uniform particle size (34–58 nm), thermal stability (> 600 °C), and magnetic properties of the nanocomposites. The nanocomposites exhibited strong synergistic effects with ciprofloxacin, reducing the minimum inhibitory concentration (MIC) in combination by 4- to 16-fold compared to ciprofloxacin alone. Furthermore, the nanocomposites in combination with ciprofloxacin significantly inhibited biofilm formation in clinical isolates. The gene expression analysis revealed downregulation of key efflux pump genes (mexX, mexY, and oprM), resulting to increased intracellular accumulation of ciprofloxacin. This mechanism potentiated the bactericidal effects of ciprofloxacin, even against resistant strains. These findings highlight the potential of Fe3O4@SPN@Silibinin as a biodegradable, stable, and water-soluble nanocarrier for silibinin delivery, offering a novel therapeutic strategy for combat multidrug-resistant bacterial infections. This study presents a promising approach to addressing the growing threat of antibiotic resistance through targeted drug delivery and genetic modulation.
- 12 July 2025
- Published by Springer Nature in 3 Biotech
- Vol. 15 (8) , 1-14
Anti-bacterial activity of silibinin-functionalized silica-coated Fe3O4 magnetic nanocomposites on Pseudomonas aeruginosa
The nanocomposites were synthesized and characterized using Fourier transform infrared spectroscopy (FT-IR), thermogravimetric analysis (TGA), transmission electron microscopy (TEM), field emission scanning electron microscopy (FE-SEM), and X-ray diffraction (XRD). The physicochemical analyses confirmed the structural integrity, uniform particle size (34–58 nm), thermal stability (> 600 °C), and magnetic properties of the nanocomposites. The nanocomposites exhibited strong synergistic effects with ciprofloxacin, reducing the minimum inhibitory concentration (MIC) in combination by 4- to 16-fold compared to ciprofloxacin alone. Furthermore, the nanocomposites in combination with ciprofloxacin significantly inhibited biofilm formation in clinical isolates. The gene expression analysis revealed downregulation of key efflux pump genes (mexX, mexY, and oprM), resulting to increased intracellular accumulation of ciprofloxacin. This mechanism potentiated the bactericidal effects of ciprofloxacin, even against resistant strains. These findings highlight the potential of Fe3O4@SPN@Silibinin as a biodegradable, stable, and water-soluble nanocarrier for silibinin delivery, offering a novel therapeutic strategy for combat multidrug-resistant bacterial infections. This study presents a promising approach to addressing the growing threat of antibiotic resistance through targeted drug delivery and genetic modulation.
- 10 July 2025
- Published by Springer Nature in 3 Biotech
- Vol. 15 (8) , 1-10
The neuroprotective effects of nanocurcumin on Parkinson’s disease markers in rats exposed to tin chloride
Tin chloride, a heavy metal compound, induces neurotoxicity and is associated with Parkinson’s disease (PD), a condition characterized by inflammation and oxidative stress. Curcumin, a polyphenolic compound, is widely recognized for its antioxidant and anti-inflammatory properties. This study examined the neuroprotective effects of nanocurcumin in a rat model of PD induced by tin (II) chloride. 20 Wistar rats were randomly assigned to four groups (n = 5/group): control, nanocurcumin (20 mg/kg), tin chloride, and tin chloride + nanocurcumin. After 4 weeks, brain tissues were analyzed histologically and for expression of inflammatory markers (IL-6, MCP-1, α-synuclein). Serum levels of superoxide dismutase (SOD), malondialdehyde (MDA), calcium (Ca2⁺), and tin were also measured. Nanocurcumin significantly attenuated tin-induced neuroinflammation and neuronal damage. Treated rats showed downregulation of IL-6, MCP-1, and α-synuclein expression (P < 0.05), increased SOD activity, and decreased MDA levels (P < 0.05). Serum Ca2⁺ levels were elevated in the nanocurcumin group, potentially reflecting reduced accumulation in brain tissues. Nanocurcumin mitigates tin chloride-induced neurotoxicity via antioxidant and anti-inflammatory mechanisms, indicating its potential as a therapeutic candidate for Parkinson’s disease.
- 10 July 2025
- Published by Springer Nature in 3 Biotech
- Vol. 15 (8) , 1-10
The neuroprotective effects of nanocurcumin on Parkinson’s disease markers in rats exposed to tin chloride
Tin chloride, a heavy metal compound, induces neurotoxicity and is associated with Parkinson’s disease (PD), a condition characterized by inflammation and oxidative stress. Curcumin, a polyphenolic compound, is widely recognized for its antioxidant and anti-inflammatory properties. This study examined the neuroprotective effects of nanocurcumin in a rat model of PD induced by tin (II) chloride. 20 Wistar rats were randomly assigned to four groups (n = 5/group): control, nanocurcumin (20 mg/kg), tin chloride, and tin chloride + nanocurcumin. After 4 weeks, brain tissues were analyzed histologically and for expression of inflammatory markers (IL-6, MCP-1, α-synuclein). Serum levels of superoxide dismutase (SOD), malondialdehyde (MDA), calcium (Ca2⁺), and tin were also measured. Nanocurcumin significantly attenuated tin-induced neuroinflammation and neuronal damage. Treated rats showed downregulation of IL-6, MCP-1, and α-synuclein expression (P < 0.05), increased SOD activity, and decreased MDA levels (P < 0.05). Serum Ca2⁺ levels were elevated in the nanocurcumin group, potentially reflecting reduced accumulation in brain tissues. Nanocurcumin mitigates tin chloride-induced neurotoxicity via antioxidant and anti-inflammatory mechanisms, indicating its potential as a therapeutic candidate for Parkinson’s disease.
- Open Access
- 1 July 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-17
Enhanced therapeutic efficacy of silibinin loaded silica coated magnetic nanocomposites against Pseudomonas aeruginosa in Combination with Ciprofloxacin and HepG2 cancer cells
Silibinin, a major bioactive compound extracted from Silybum marianum, possesses notable antioxidant, antitumor, hepatoprotective, and antibacterial activities. However, its poor solubility limits its clinical applications. This study aimed to enhance the delivery of silibinin by synthesizing magnetic nanocomposites (MNCs) and evaluating their efficacy against clinical isolates of Pseudomonas aeruginosa and HepG2 cancer cells. The physicochemical properties of the Fe3O4@SiPr@Silibinin nanocomposites were characterized by FT-IR, TGA-DTG, TEM, FE-SEM, XRD, and VSM analysis. Clinical isolates and a standard strain of P. aeruginosa were treated with Fe3O4@SiPr@Silibinin (at sub-MIC level) in combination with ciprofloxacin (sub-MIC), and the results were compared to treatment with ciprofloxacin alone. Additionally, the anticancer effects of Fe3O4@SiPr@Silibinin were evaluated in HepG2 cells. The nanocomposites, with particle sizes ranging from 40 to 80 nm, significantly enhanced the antimicrobial activity of ciprofloxacin when used in combination. Treatment with Fe3O4@SiPr@Silibinin plus ciprofloxacin led to a downregulation of biofilm and efflux pump-related gene expression compared to ciprofloxacin treatment alone. Furthermore, Fe3O4@SiPr@Silibinin exhibited anti-cancer activity against HepG2 cells, with an IC₅₀ value of 35.79 µg/mL In Silibinin-treated HepG2 cells, upregulation of the P53 gene and downregulation of the Bcl2 gene were observed. Our findingssuggest that Fe3O4@SiPr@Silibinin MNCs, with high stability and water solublity, can efficiently deliver silibinin into pathogenic and tumorigenic cells, thereby enhancing its therapeutic effects against P. aeruginosa and HepG2 cells. Given the antimicrobial and antitumor properties of silibinin, these magnetic nanocarriers represent a promising strategy for its targeted delivery.
- 1 July 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-17
Open AccessEnhanced therapeutic efficacy of silibinin loaded silica coated magnetic nanocomposites against Pseudomonas aeruginosa in Combination with Ciprofloxacin and HepG2 cancer cells
Silibinin, a major bioactive compound extracted from Silybum marianum, possesses notable antioxidant, antitumor, hepatoprotective, and antibacterial activities. However, its poor solubility limits its clinical applications. This study aimed to enhance the delivery of silibinin by synthesizing magnetic nanocomposites (MNCs) and evaluating their efficacy against clinical isolates of Pseudomonas aeruginosa and HepG2 cancer cells. The physicochemical properties of the Fe3O4@SiPr@Silibinin nanocomposites were characterized by FT-IR, TGA-DTG, TEM, FE-SEM, XRD, and VSM analysis. Clinical isolates and a standard strain of P. aeruginosa were treated with Fe3O4@SiPr@Silibinin (at sub-MIC level) in combination with ciprofloxacin (sub-MIC), and the results were compared to treatment with ciprofloxacin alone. Additionally, the anticancer effects of Fe3O4@SiPr@Silibinin were evaluated in HepG2 cells. The nanocomposites, with particle sizes ranging from 40 to 80 nm, significantly enhanced the antimicrobial activity of ciprofloxacin when used in combination. Treatment with Fe3O4@SiPr@Silibinin plus ciprofloxacin led to a downregulation of biofilm and efflux pump-related gene expression compared to ciprofloxacin treatment alone. Furthermore, Fe3O4@SiPr@Silibinin exhibited anti-cancer activity against HepG2 cells, with an IC₅₀ value of 35.79 µg/mL In Silibinin-treated HepG2 cells, upregulation of the P53 gene and downregulation of the Bcl2 gene were observed. Our findingssuggest that Fe3O4@SiPr@Silibinin MNCs, with high stability and water solublity, can efficiently deliver silibinin into pathogenic and tumorigenic cells, thereby enhancing its therapeutic effects against P. aeruginosa and HepG2 cells. Given the antimicrobial and antitumor properties of silibinin, these magnetic nanocarriers represent a promising strategy for its targeted delivery.